Glaukos Corp Files Q3 2024 10-Q

TL;DR

GKOS Q3 2024 10-Q is in. Financials look steady, no major red flags.

AI Summary

Glaukos Corporation (GKOS) filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Key financial data and balance sheet information are presented, reflecting the company's ongoing business activities and financial position.

Why It Matters

This filing provides investors with the latest financial snapshot of Glaukos, crucial for understanding the company's performance and making informed investment decisions.

Risk Assessment

Risk Level: low — The filing is a standard quarterly report and does not indicate any immediate or unusual risks.

Key Numbers

• 2024-09-30 — Report End Date (Indicates the period covered by the financial statements.)
• 2024-11-05 — Filing Date (The date the report was officially submitted to the SEC.)

Key Players & Entities

• GLAUKOS Corp (company) — Filer of the 10-Q
• 0001558370-24-014295 (other) — Accession Number for the filing
• 20240930 (date) — Conformed period of report
• 20241105 (date) — Filing date
• 949-367-9600 (other) — Business phone number

FAQ

Key Financial Figures

• $0.001 — hares of the registrant's Common Stock, $0.001 par value per share, outstanding. Tab

Filing Documents

• gkos-20240930x10q.htm (10-Q) — 2155KB
• gkos-20240930xex31d1.htm (EX-31.1) — 16KB
• gkos-20240930xex31d2.htm (EX-31.2) — 17KB
• gkos-20240930xex32d1.htm (EX-32.1) — 7KB
• gkos-20240930xex32d2.htm (EX-32.2) — 8KB
• 0001558370-24-014295.txt ( ) — 8783KB
• gkos-20240930.xsd (EX-101.SCH) — 46KB
• gkos-20240930_cal.xml (EX-101.CAL) — 75KB
• gkos-20240930_def.xml (EX-101.DEF) — 169KB
• gkos-20240930_lab.xml (EX-101.LAB) — 468KB
• gkos-20240930_pre.xml (EX-101.PRE) — 322KB
• gkos-20240930x10q_htm.xml (XML) — 1780KB

: FINANCIAL INFORMATION

PART I : FINANCIAL INFORMATION 5 Item 1.

Financial Statements

Financial Statements 5 Condensed Consolidated Balance Sheets 5 Condensed Consolidated Statements of Operations 6 Condensed Consolidated Statements of Comprehensive Loss 7 Condensed Consolidated Statements of Stockholders' Equity 8 Condensed Consolidated Statements of Cash Flows 9 Notes to Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 26 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 38 Item 4.

Controls and Procedures

Controls and Procedures 38

: OTHER INFORMATION

PART II : OTHER INFORMATION 39 Item 1.

Legal Proceedings

Legal Proceedings 39 Item1A.

Risk Factors

Risk Factors 39 Item 6. Exhibits 54

SIGNATURES

SIGNATURES 55 2 Table of Contents Note Regarding Forward-Looking Statements This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act) All statements other than statements of historical or current facts included in this report are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Any statements in this Quarterly Report on Form 10-Q regarding future operations, including our expectations for future expenses, capital expenditures and income, our expectations regarding the impact of the macroeconomic environment, our strategy for growth, product development activities, the impact of the regulatory environment, including the timing and likelihood of regulatory approvals and the impact of new or changing regulations and pricing, and market position are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions based on the information available to management at the time of this report. Although we believe that we have a reasonable basis for each forward-looking statement contained in this report, we caution you that these forward-looking statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. You are urged to carefully review the disclosures we make concerning the risks we face and other factors that may affect the o

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements GLAUKOS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par values) September 30, December 31, 2024 2023 (unaudited) Assets Current assets: Cash and cash equivalents $ 100,143 $ 93,467 Short-term investments 162,330 201,964 Accounts receivable, net 56,408 39,850 Inventory 59,895 41,986 Prepaid expenses and other current assets 18,506 18,194 Total current assets 397,282 395,461 Restricted cash 4,733 5,856 Property and equipment, net 98,581 103,212 Operating lease right-of-use assets 27,321 27,146 Finance lease right-of-use asset 42,365 44,180 Intangible assets, net 269,418 282,956 Goodwill 66,134 66,134 Deposits and other assets 20,709 15,469 Total assets $ 926,543 $ 940,414 Liabilities and stockholders' equity Current liabilities: Accounts payable $ 11,103 $ 13,440 Accrued liabilities 60,581 60,574 Total current liabilities 71,684 74,014 Convertible senior notes 56,759 282,773 Operating lease liability 30,656 30,427 Finance lease liability 69,712 70,538 Deferred tax liability, net 7,143 7,144 Other liabilities 22,080 13,752 Total liabilities 258,034 478,648 Commitments and contingencies (Note 12) Stockholders' equity: Preferred stock, $ 0.001 par value; 5,000 shares authorized; no shares issued or outstanding - - Common stock, $ 0.001 par value; 150,000 shares authorized; 55,122 and 49,148 shares issued and 55,094 and 49,120 shares outstanding as of September 30, 2024 and December 31, 2023, respectively 55 49 Additional paid-in capital 1,377,825 1,059,751 Accumulated other comprehensive income 2,620 1,165 Accumulated deficit ( 711,859 ) ( 599,067 ) Less treasury stock ( 28 shares as of September 30, 2024 and December 31, 2023) ( 132 ) ( 132 ) Total stockholders' equity 668,509 461,766 Total liabilities and stockholders' equity $ 926,543

View Full Filing

View this 10-Q filing on SEC EDGAR